Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
It is our intent to develop a cell culture model of tissue extracellular
matrix injury. Cultured smooth muscle cells, with time, form a
multilayered cell system containing cells embedded in an extracellular
matrix in a "hills and valleys" format. If we liken this cell layer to the
simplest of tissue specimens, we hypothesize that under normal
circumstances minor injury to the extracellular matrix will provoke
cellular responses leading to rapid, normal repair. When injury to the
matrix is beyond normal repair, it is hypothesized that cellular responses
occur which trigger additional damage, including those derived from
infiltration of inflammatory cells, ultimately resulting in permanent loss
of functional connective tissue (fibrotic or non-fibrotic). The focus of
the proposal is to understand the relationships between matrix injury and
cellular response and repair. Within the confines of the culture system,
we will produce a biochemically defined matrix which, in turn, can be
injured in a controlled and measureable manner and ultimately can be
repaired by the cells embedded in the matrix. Preliminary studies are
encouraging and suggest that this approach is feasible. Matrices can be
developed in which the collagen, elastin, proteoglycan or fibronectin
components may be labelled. In addition, the matrix content of collagen
and elastin can be altered with various agents such as ascorbate and
estradiol. These labelled defined matrices of varying composition are to
be injured by treatment with leukocytic elastase and/or myeloperoxidase.
The injury will be measured by a number of parameters including degradation
or solubilization of labelled components and ultrastructural damage. The
cellular response to the injury will be evaluated by monitoring the ability
of the cells in culture to synthesize new matrix components and repair the
damaged components, to proliferate and/or produce metabolites such as
prostaglandins. In addition, attempts will be made to modulate these
responses by the addition of agents such as prostaglandins and ascorbate.
Findings from these studies should lead to new insights into the
relationship between tissue injury and the pathogenesis of artery diseases
such as atherosclerosis.
No Sub Projects information available for 5R01HL033522-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HL033522-03
Patents
No Patents information available for 5R01HL033522-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HL033522-03
Clinical Studies
No Clinical Studies information available for 5R01HL033522-03
News and More
Related News Releases
No news release information available for 5R01HL033522-03
History
No Historical information available for 5R01HL033522-03
Similar Projects
No Similar Projects information available for 5R01HL033522-03